University Hospital, Basel, Switzerland: Communicable Diseases trials

The registry lists 24 Communicable Diseases studies with University Hospital, Basel, Switzerland as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 3Phase 3 1Phase 4 1No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus InfectionRecruitingNCT05655091Phase 2
• Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV InfectionRecruitingNCT05127980
• COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)RecruitingNCT04625257
• Alternative Prophylaxis in Female Recurrent Urinary Tract InfectionsRecruitingNCT04095572Phase 4
• A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®RecruitingNCT02007356Phase 2
• Antibiotic Therapy in Infections of the Diabetic Foot SyndromeCompletedNCT05616351
• Functional Outcome Following Surgical Treatment of Patients With Sternoclavicular Joint InfectionCompletedNCT05234385
• Is the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice?CompletedNCT05117671
• Staphylococcus Aureus Caught in Action at the Site of InfectionCompletedNCT04781569
• Prolonged Cardiopulmonary Bypass Time as Predictive Factor for in Hospital InfectionCompletedNCT04548167
• Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus AureusCompletedNCT04503252
• Long--term Outcome Analysis of Fracture--related InfectionsCompletedNCT04455217
• Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19TerminatedNCT04414631Phase 2
• Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19CompletedNCT04389944Not applicable
• Construct Validation of the BIOTICA QuestionnaireCompletedNCT04286230
• Oral Corticosteroids for Post-infectious Cough in AdultsTerminatedNCT04232449Phase 3
• Number of Necessary Paints of Preoperative Skin Disinfection to Prevent Surgical Site InfectionsCompletedNCT03859375
• Drains and Surgical Site InfectionsCompletedNCT03408782
• Routine Antibiotic Prescription Monitoring in Primary Care Physicians: A Nationwide TrialCompletedNCT03379194Not applicable
• Simplified GBS Screening and Prevalence of ESBL in Pregnant WomenCompletedNCT02142933Not applicable
• Routine Prescription Feedback and Peer Comparison to Lower Antibiotic Prescriptions in Primary CareCompletedNCT01773824Not applicable
• Clinical Outcome in View of Surgical Site Infection (SSI) With Antibacterial Skin SuturesTerminatedNCT01540279
• Patient Centered Communication Training to Reduce Antibiotic Use in Acute Respiratory Tract InfectionsCompletedNCT00105248Not applicable
• Procalcitonin Guided Antibiotic Use in Acute Respiratory Tract Infections (PARTI)-StudyCompletedNCT00099840Not applicable